INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,614,000 | -9.7% | 14,846 | +36.7% | 0.00% | 0.0% |
| Q3 2016 | $1,787,000 | +6.7% | 10,857 | -7.6% | 0.00% | 0.0% |
| Q2 2016 | $1,675,000 | -0.3% | 11,748 | -10.1% | 0.00% | 0.0% |
| Q1 2016 | $1,680,000 | +3.3% | 13,074 | +20.1% | 0.00% | 0.0% |
| Q4 2015 | $1,626,000 | -9.0% | 10,886 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $1,786,000 | -27.8% | 10,771 | +5.2% | 0.00% | 0.0% |
| Q2 2015 | $2,473,000 | +6.2% | 10,242 | +24.1% | 0.00% | 0.0% |
| Q1 2015 | $2,328,000 | +141.2% | 8,253 | +33.3% | 0.00% | 0.0% |
| Q4 2014 | $965,000 | -26.7% | 6,189 | +11.3% | 0.00% | 0.0% |
| Q3 2014 | $1,317,000 | -59.3% | 5,563 | -59.4% | 0.00% | -50.0% |
| Q2 2014 | $3,239,000 | +370.8% | 13,686 | +555.8% | 0.00% | – |
| Q1 2014 | $688,000 | – | 2,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |